ID

36805

Description

Relationship Between Symptoms, Retinal Morphology, and the Nigrostriatal Dopamine System in Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT02443779

Link

https://clinicaltrials.gov/show/NCT02443779

Keywords

  1. 6/11/19 6/11/19 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 11, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Parkinson's Disease NCT02443779

Eligibility Parkinson's Disease NCT02443779

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. willing and able to give informed consent.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
2. between the ages of 50-80 years old.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
3. male or female with idiopathic pd who fulfill uk pd society brain bank criteria for diagnosis of parkinson's disease.
Description

Parkinson Disease

Data type

boolean

Alias
UMLS CUI [1]
C0030567
5. later stage subjects will need to have unified parkinson's disease rating scale motor scores of > 20 and be > 5 years from diagnosis
Description

Parkinson Disease Late stage Unified Parkinson's Disease Rating Scale | Disease length

Data type

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C0544467
UMLS CUI [1,3]
C3639721
UMLS CUI [2]
C0872146
6. if female, one of the following three scenarios must apply:
Description

Gender

Data type

boolean

Alias
UMLS CUI [1]
C0079399
at least two years post-menopausal
Description

Postmenopausal state

Data type

boolean

Alias
UMLS CUI [1]
C0232970
surgically sterile
Description

Female Sterilization

Data type

boolean

Alias
UMLS CUI [1]
C0015787
negative urine pregnancy test, and following a reliable method of birth control (oral contraceptive, intrauterine device, contraceptive implant, barrier, or abstinence) for at least two months prior to entry, and agreeing both to follow a reliable method of birth control, and (if relevant) to desist from breast feeding during, and for two weeks following tracer administration.
Description

Urine pregnancy test negative | Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraceptive implant | Contraception, Barrier | Sexual Abstinence | Breast Feeding To be stopped

Data type

boolean

Alias
UMLS CUI [1]
C0430057
UMLS CUI [2]
C0700589
UMLS CUI [3]
C0009905
UMLS CUI [4]
C0021900
UMLS CUI [5]
C1657106
UMLS CUI [6]
C0004764
UMLS CUI [7]
C0036899
UMLS CUI [8,1]
C0006147
UMLS CUI [8,2]
C1272691
Concomitant Medications
Description

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Were any concomitant medications taken by the subject prior to screening and/or during the study?
Description

Concomitant Agent

Data type

boolean

Alias
UMLS CUI [1]
C2347852
Drug Name
Description

Concomitant Agent, Medication name

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
Unit Dose
Description

Concomitant Agent, Dosage

Data type

integer

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0178602
Units
Description

Concomitant Agent, Unit

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0439148
Frequency
Description

Concomitant Agent, Frequencies

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0439603
Route
Description

Concomitant Agent, Drug Administration Routes

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013153
Reason for Medication
Description

Concomitant Agent, Indication

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3146298
Taken Prior to Study?
Description

Concomitant Medication Previous Occurrence

Data type

boolean

Alias
UMLS CUI [1]
C2826667
Stop Date
Description

Concomitant Medication End Date

Data type

date

Alias
UMLS CUI [1]
C2826744
Stop Time
Description

Concomitant Agent, End Time

Data type

time

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1522314
Ongoing Medication?
Description

Concomitant Medication Ongoing

Data type

boolean

Alias
UMLS CUI [1]
C2826666

Similar models

Eligibility Parkinson's Disease NCT02443779

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
1. willing and able to give informed consent.
boolean
C0021430 (UMLS CUI [1])
Age
Item
2. between the ages of 50-80 years old.
boolean
C0001779 (UMLS CUI [1])
Parkinson Disease
Item
3. male or female with idiopathic pd who fulfill uk pd society brain bank criteria for diagnosis of parkinson's disease.
boolean
C0030567 (UMLS CUI [1])
Parkinson Disease Late stage Unified Parkinson's Disease Rating Scale | Disease length
Item
5. later stage subjects will need to have unified parkinson's disease rating scale motor scores of > 20 and be > 5 years from diagnosis
boolean
C0030567 (UMLS CUI [1,1])
C0544467 (UMLS CUI [1,2])
C3639721 (UMLS CUI [1,3])
C0872146 (UMLS CUI [2])
Gender
Item
6. if female, one of the following three scenarios must apply:
boolean
C0079399 (UMLS CUI [1])
Postmenopausal state
Item
at least two years post-menopausal
boolean
C0232970 (UMLS CUI [1])
Female Sterilization
Item
surgically sterile
boolean
C0015787 (UMLS CUI [1])
Urine pregnancy test negative | Contraceptive methods | Contraceptives, Oral | Intrauterine Devices | Contraceptive implant | Contraception, Barrier | Sexual Abstinence | Breast Feeding To be stopped
Item
negative urine pregnancy test, and following a reliable method of birth control (oral contraceptive, intrauterine device, contraceptive implant, barrier, or abstinence) for at least two months prior to entry, and agreeing both to follow a reliable method of birth control, and (if relevant) to desist from breast feeding during, and for two weeks following tracer administration.
boolean
C0430057 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
C0009905 (UMLS CUI [3])
C0021900 (UMLS CUI [4])
C1657106 (UMLS CUI [5])
C0004764 (UMLS CUI [6])
C0036899 (UMLS CUI [7])
C0006147 (UMLS CUI [8,1])
C1272691 (UMLS CUI [8,2])
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Concomitant Agent
Item
Were any concomitant medications taken by the subject prior to screening and/or during the study?
boolean
C2347852 (UMLS CUI [1])
Concomitant Agent, Medication name
Item
Drug Name
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
Concomitant Agent, Dosage
Item
Unit Dose
integer
C2347852 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Concomitant Agent, Unit
Item
Units
text
C2347852 (UMLS CUI [1,1])
C0439148 (UMLS CUI [1,2])
Concomitant Agent, Frequencies
Item
Frequency
text
C2347852 (UMLS CUI [1,1])
C0439603 (UMLS CUI [1,2])
Concomitant Agent, Drug Administration Routes
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Concomitant Agent, Indication
Item
Reason for Medication
text
C2347852 (UMLS CUI [1,1])
C3146298 (UMLS CUI [1,2])
Concomitant Medication Previous Occurrence
Item
Taken Prior to Study?
boolean
C2826667 (UMLS CUI [1])
Concomitant Medication End Date
Item
Stop Date
date
C2826744 (UMLS CUI [1])
Concomitant Agent, End Time
Item
Stop Time
time
C2347852 (UMLS CUI [1,1])
C1522314 (UMLS CUI [1,2])
Concomitant Medication Ongoing
Item
Ongoing Medication?
boolean
C2826666 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial